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Abstract
Background: Molecular mechanisms generating genetic variation provide the basis for evolution and long-term
survival of a population in a changing environment. In stable, laboratory conditions, the variation-generating
mechanisms are dispensable, as there is limited need for the cell to adapt to adverse conditions. In fact, newly
emerging, evolved features might be undesirable when working on highly refined, precise molecular and synthetic
biological tasks.
Results: By constructing low-mutation-rate variants, we reduced the evolutionary capacity of MDS42, a reduced-
genome E. coli strain engineered to lack most genes irrelevant for laboratory/industrial applications. Elimination of
diversity-generating, error-prone DNA polymerase enzymes involved in induced mutagenesis achieved a significant
stabilization of the genome. The resulting strain, while retaining normal growth, showed a significant decrease in
overall mutation rates, most notably under various stress conditions. Moreover, the error-prone polymerase-free
host allowed relatively stable maintenance of a toxic methyltransferase-expressing clone. In contrast, the parental
strain produced mutant clones, unable to produce functional methyltransferase, which quickly overgrew the
culture to a high ratio (50% of clones in a 24-h induction period lacked functional methyltransferase activity). The
surprisingly large stability-difference observed between the strains was due to the combined effects of high stress-
induced mutagenesis in the parental strain, growth inhibition by expression of the toxic protein, and selection/
outgrowth of mutants no longer producing an active, toxic enzyme.
Conclusions: By eliminating stress-inducible error-prone DNA-polymerases, the genome of the mobile genetic
element-free E. coli strain MDS42 was further stabilized. The resulting strain represents an improved host in various
synthetic and molecular biological applications, allowing more stable production of growth-inhibiting
biomolecules.
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Background
Intrinsic mechanisms for generating diversity are impor-
tant for survival of bacterial populations in dynamically
changing environmental conditions. The ability of a
population to adapt to various situations is largely depen-
dent upon a constant fine-tuning of mutation rate [1].
However, what is beneficial in a natural environment is
not necessary when conditions are relatively stable and
controlled, as in laboratory and industrial settings. In
fact, novel, evolved features arising in a carefully designed
and fabricated system of biological parts can lead to
unwanted genotypic and phenotypic alterations, and the
spontaneous genetic modification of an established pro-
duction strain or a clone library is usually highly undesir-
able [2]. Consequently, whether used as a production
strain, a cloning host, or as a synthetic biological chassis,
a bacterial cell with increased genetic stability is of great
importance [3-5].
In addition to being a universal cloning host, Escherichia
coli is the most common organism used in the production
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any medium, provided the original work is properly cited.of proteins, metabolites, and secondary metabolites, for
both research and industrial purposes [6-12]. In an effort
to improve the performance of these ‘workhorse’ strains,
several large-scale modifications have been made to var-
ious E. coli strains using genome engineering methods
[13-17]. These efforts all follow the basic principle of
streamlining metabolic pathways for the increased produc-
tion of a given biomaterial coupled with reduction of
unwanted byproducts. Along these lines, a reduced-gen-
ome E. coli strain (MDS42) was constructed in our labora-
tories. Most genes irrelevant for laboratory applications, as
well as all known mobile DNA sequences and cryptic viru-
lence genes were precisely deleted, resulting in a geneti-
cally stabilized strain that displays several advantageous
properties [18]. The advantages of using an MDS42 back-
ground for industrial purposes was demonstrated by
increased L-threonine production in a modified version of
the multi-deletion strain [19]. In a recent work, we have
also shown that the IS element-free MDS42 host improves
maintenance of unstable genetic constructs, allowing for
stable cloning of certain toxic genes [20].
Evidence exists that some genes, in their functional
forms, are unusually difficult to clone in bacterial plas-
mids, and aberrant clones frequently arise [21-24].
Normally, the general mutation rate of the host cell is so
low (~10
-7 mutation/gene/generation) [25], that sponta-
neous changes in a cloned DNA fragment are extremely
rare and therefore cannot solely account for the cloning
artifacts. However, when the cloned DNA fragment inter-
feres with normal cell physiology and reduces growth, the
rare mutants of the clone can be positively selected for
and can rapidly become dominant in the culture. This
phenomenon became apparent to us in an earlier attempt
to clone the VP60 gene of rabbit hemorrhagic virus [18].
VP60 fused to a cholera toxin component proved to be
toxic to the cell. Inactivation of the recombinant gene due
to IS element-transposition and insertion into the toxic
gene, followed by rapid selection of the mutants, resulted
in only aberrant clones in normal E. coli cloning hosts.
Using the MDS42 host cell free of all IS elements, the
recombinant gene could be cloned in its intact form.
Here we wish to expand this work by making further
improvements on the genetic stability of MDS42. Beyond
the previous elimination of all IS insertion events, we dis-
abled other mutation-generating pathways of the host in
order to improve tolerance and fidelity. Removal of IS ele-
ments from the host genome eliminated a major, some-
times dominant [26] form of mutation generation.
However, in many cases, toxic clones are inactivated by
point mutations or deletions. A detailed analysis of clones
of hepatitis C virus genes showed that the cloning proce-
dure in E. coli resulted exclusively in defective, non-
expressing clones due to the selection of point mutants
(either frameshifts or stop codons) [24]. Selection of
defective forms of toxic genes can be so effective, that it
can actually be used deliberately to obtain point mutants,
as demonstrated by isolation of mutants of human immu-
nodeficiency virus protease [27] or of the PvuII DNA
methyltransferase [28]. Unlike insertion mutagenesis by IS
elements, point mutations as a whole cannot be totally
eliminated. Nevertheless, any reduction in mutation rate
expands the cloning potential of the host cell and
improves its function as a synthetic biological chassis.
Our strategy for reducing point mutation rate in E. coli
involved disabling the effective mutation generating
enzymes of the SOS response. Under stressful conditions
(e.g. toxic clones harbored in the cell), DNA damage may
occur, activating the SOS response, inducing approxi-
mately 40 members of the SOS regulon [29-32]. Three of
the genes induced during the SOS response of E. coli
encode DNA polymerases (Pol II, Pol IV, Pol V) that are
able to bypass replication barriers at damaged sites and
stalled replication forks [33-36]. All three of the SOS-indu-
cible polymerases have been implicated in induced muta-
g e n e s i s[ 3 7 ] ,w i t hP o lI Va n dP o lVh a v i n ge r r o r - r a t e s
approximately 2 to 3 orders of magnitude higher than the
high-fidelity replicative polymerase (Pol III) [38]. Pol II,
while showing high fidelity on undamaged templates, was
shown to take part in certain types of stress-induced
mutagenesis [37,39,40]. The SOS-regulated polymerases
are dispensable; their primary role seems to be the genera-
tion of genetic diversity under stressful conditions [41].
DNA repair has alternative pathways, most notably recom-
bination-mediated repair, which can rescue stalled replica-
tion in a less error-prone manner [42].
We show here that the disabling of stress-induced muta-
genesis mechanisms further increases the genetic stability
of MDS42, a reduced-genome E. coli strain lacking all
mobile genetic elements. We offer proof of the beneficial
effects of the resulting strain as a cloning host in the stable
maintenance of a toxic gene. The improved strain shows
promising potential as a cellular chassis for molecular and
synthetic biological applications.
Results
The absence of error-prone polymerases reduces the
spontaneous mutation rate
The SOS-induced minor (error-prone) DNA-polymerases
are major factors in generating point mutations. In a pub-
lished attempt, prevention of derepression of SOS regulon
genes was accomplished by introducing a mutation in the
primary regulator LexA, disabling the autocatalytic clea-
vage process involved in the regulation [43]. The muta-
tion-decreasing effect of such a LexA variant was shown
to prevent E. coli cells from developing antibiotic resistant
topoisomerase mutations [44]. Alternatively, direct dele-
tion of all three SOS-inducible DNA polymerase genes
could reduce the mutation rate. Since these polymerases
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absence of stress, and, moreover, they can be activated by
stress-induced pathways other than the SOS response [45]
(Figure 1), we opted for the scarless removal of the genes
encoding PolII (polB), PolIV (dinB), and PolV (umuDC).
For comparison, LexA and RecA mutants [46], unable to
induce the SOS pathway, were also analyzed.
The genes coding for the three error-prone DNA poly-
merases (polB, dinB, umuDC) were deleted from the gen-
ome of MDS42 in a scarless manner using a suicide
plasmid-based method [47]. Gene deletions were made
individually and also joined in all possible combinations.
The spontaneous mutation rate of each strain was then
determined using a D-cycloserine resistance assay, detect-
ing all types of mutations in the cycA gene [48].
The deletion of each error-prone polymerase gene by
itself results in at least a 20% decrease in mutation rate
(Figure 2) measured with this method. When combining
the different deletions, the mutation rate decreased
further, with the lowest mutation rates being that of
MDS42polBdinB (MDS42pd) and the triple deletion
strain MDS42polBdinBumuDC (MDS42pdu). Compared
to their parent MDS42, these strains showed a close to
50% decrease in spontaneous mutation rate (8.2*10
-8
mutation/cell/generation decreased to 4.34*10
-8 and
4.45*10
-8, respectively). The difference observed between
wild-type MG1655 and MDS42 is due to the absence of
insertion events [18].
To verify that the absence of the error-prone DNA
polymerases has no adverse effect on fitness, growth
rates of the different strains were measured in MOPS
minimal medium. 14 parallel cultures originating from
14 individual colonies for each strain were picked and
grown in a Bioscreen C instrument (Figure 3). We found
that none of the deletions had a significant effect on fit-
ness in MOPS minimal medium, even when combined in
the triple deletion strain MDS42pdu. This strain was
then chosen for further analysis.
As an additional measure of fitness, we analyzed the sur-
vival rate of MDS42pdu and MDS42 in long-term stationary
SOS response 
General stress response 
Heat-shock response 
Stringent response 
Polyphosphate-mediated 
nutrient-limitation response 
Mutagenesis in aging 
colonies 
Antibiotic-induced 
mutagenesis 
RecA,LexA 
GroE 
RpoS 
(p)ppGpp, DskA 
PolyP, Ppk, Ppx 
quinolones, β-lactams 
polB, dinB, umuDC 
Figure 1 Inducers of the error-prone polymerase genes. Besides the well-documented SOS response-mediated pathway, error-prone DNA
polymerase genes can be activated by several different routes. Main pathways are indicated in the boxes, with the main interacting partners
indicated below each. (Adapted from [45]).
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Page 3 of 13phase (Additional file 1). No significant difference was
observed between the two strains over a period of 7 days.
Furthermore, when the two strains were additionally
stressed by expressing a moderately toxic protein from the
pSin32 plasmid (discussed later), the survival rates in sta-
tionary phase were not significantly different either.
Inactivation of the regulators of the SOS response does
not lower the spontaneous mutation rate
T os e ew h e t h e rt h ei n a c t i v a t i o no ft h ew h o l eS O S
response via regulator mutants would have the same
effects on the spontaneous mutation rate as elimination
of the error-prone DNA polymerases, MDS42recA and
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Figure 2 Spontaneous mutation rates of error-prone polymerase deletion mutant and control strains. Mutation rates were determined
by the fluctuation analysis of D-cycloserine-resistant mutants [48]. Gene names are indicated for the single-deletion strains, while MDS42pd,
MDS42pu, MDS42du, and MDS42pdu denote MDS42polBdinB, MDS42polBumuDC, MDS42dinBumuDC, and MDS42polBdinBumuDC, respectively.
Error bars represent 95% confidence intervals for the average of 4 independent measurements. ANOVA revealed a significance of p < 0.005.
Pairwise t-tests were conducted for each strain compared to the MDS42 strain, * indicates a significance of p < 0.05, ** indicates a significance
of p < 0.01, *** indicates a significance of p < 0.001.
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Figure 3 Doubling times of strains used in the study. Doubling times were measured in MOPS minimal medium at 37°C in microtiter plates
(see methods). Error bars represent 95% confidence intervals for the average of 14 independent measurements. ANOVA revealed a significance
of p < 0.005. Pairwise t-tests were conducted for each strain compared to the MDS42 strain, none of the strains showed a significant difference.
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modifications had an adverse effect on the overall fitness
of the strains (Figure 3). Spontaneous mutation rates of
these SOS-disabled strains were analyzed by the D-
cycloserine resistance fluctuation assay. Neither strain
showed a significant decrease in spontaneous mutation
rate when compared to MDS42 (Figure 4).
MDS42pdu is genetically stable under stress conditions
Due to the stress-induced nature of the error-prone DNA
polymerases, it was expected that the difference in muta-
tion rates of the polymerase-free and the parent strain
would be even more pronounced under stressful condi-
tions. Mutation rates were therefore measured under
stressful conditions, including the application of an anti-
biotic agent (mitomycin-C), overproduction of benign
Green Fluorescent Protein (GFP) [49,50], and overproduc-
tion of a toxic protein (ORF238) [20].
Mitomycin-C, a DNA cross-linking agent that causes
lesions in double-stranded DNA [51], directly activates the
SOS response, leading to the up-regulation of error-prone
DNA polymerase enzymes. A sub-inhibitory concentration
(0.1 μg/ml) of mitomycin-C was used to stress the cells
and analyze the effect on mutation rates. Protein overpro-
duction imposes stress on the host cell [52,53]. To test the
effect of overproduction on mutation rates, genes for
either non-toxic GFP, or the toxic small, leucine-rich
hydrophobic protein ORF238 [53] were cloned on plas-
mids as inducible constructs controlled by a T7 promoter.
To express them, T7 RNA polymerase encoding variants
of the studied strains were constructed. Fitness measure-
ments of these modified strains revealed no significant
decrease compared to MDS42 (Additional file 2). In addi-
tion to MDS42pdu and its parent MDS42, the widely used
protein production strain BL21(DE3), the wild-type K-12
MG1655, and also the two different SOS-inactivated var-
iants of MDS42 (MDS42recA and MDS42lexA(S119A))
were tested (Figure 4).
Results showed that, with the exception of MDS42recA
and MDS42pdu, the various stresses generally increased
the mutation rate. Overproduction of the toxic ORF238
protein had the largest effect: a > 5-fold increase in muta-
tion rate was measured. Sub-inhibitory concentration of
mitomycin-C caused a > 2-3-fold increase in the mutation
rate (BL21(DE3) and MDS42recA were unable to grow
under these conditions). The overproduction of GFP had a
minor effect, a 1.5 to 2-fold increase in mutation rate.
In contrast, no significant increase in mutation rate in
the presence of any of the stressors could be seen in either
MDS42recA or MDS42pdu. (Interestingly, MDS42lexA
5.0E-06
4.0E-06
1.2E-06
1.0E-06
8.0E-07
6.0E-07
4.0E-07
2.0E-07
0.0E+00
6.0E-06
7.0E-06
BL21(DE3)
MG1655
MDS42
MDS42recA
MDS42lexA(S119A)
MDS42pdu
M
u
t
a
t
i
o
n
 
r
a
t
e
(
m
u
t
a
t
i
o
n
/
g
e
n
e
/
g
e
n
e
r
a
t
i
o
n
)
unstressed
pET-GFP
pSG-ORF238
mitomycin
* 
** * 
** 
* 
** 
** 
*** 
* 
*** 
*** 
*** 
** 
** 
** 
Figure 4 Mutation rates of various strains under unstressed and stressful conditions. Stress conditions include overproduction of GFP,
overproduction of a toxic peptide from pSG-ORF238, and treatment with mitomycin-C. All measurements were made using the cycA fluctuation
assay, error bars represent 95% confidence intervals for the average of 3 independent measurements. BL21(DE3) and MDS42recA failed to grow
in the presence of 0.1 μg/ml mitomycin-C. ANOVA revealed a significance of p < 0.0001. Pairwise t-tests were conducted for each strain under a
given condition compared to the corresponding MDS42pdu strain, * indicates a significance of p < 0.05, ** indicates a significance of p < 0.01,
*** indicates a significance of p < 0.001.
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Page 5 of 13(S119A) did not follow this behavior, the strain showed an
increase in mutation rate in response to all of the stresses.)
MDS42pdu can be characterized as the genetically most
stable strain, displaying the lowest spontaneous mutation
rate and showing negligible response to stressful
conditions.
It is also noteworthy that the commonly used protein
production strain BL21(DE3) showed a mutation rate
almost two orders of magnitude higher than MDS42pdu.
To study what this difference could be attributed to, the
mutational spectra of BL21(DE3), MG1655, MDS42, and
MDS42pdu were studied by PCR analysis of cycA in cyclo-
serine-resistant mutants (Figure 5). In MG1655, 74% of
the mutations proved to be point mutations, 24% were IS
insertions, and 2% were deletions. In contrast, in BL21
(DE3), 77% of cycA mutations were IS insertions. Although
the proportion of point mutations in BL21(DE3) was
much smaller (74% in MG1655 versus 23% in BL21(DE3)),
the actual rate of point mutations was also over 2-fold
higher in BL21(DE3) (2.28*10
-7 compared to 9.2*10
-8 in
MG1655). No deletions were found among the cycA alleles
in BL21(DE3).
To confirm the data obtained using the cycA fluctuation
assay, mutation rates of MDS42 and MDS42pdu under
each of the different stress conditions were also measured
using a second assay. The data obtained using the
rifampicin resistance assay (detecting point mutations in
the essential rpoB gene [54]) were consistent with the cycA
fluctuation assay data (Additional file 3). MDS42pdu had a
2-fold lower spontaneous mutation frequency compared
to MDS42. In response to the overproduction of the toxic
ORF238 protein, as well as in the presence of mitomycin-
C, the mutation rate of MDS42 became significantly ele-
vated, while the response of MDS42pdu was much less
substantial.
The error-prone polymerase-free strain provides
improved stability to a toxic protein-expressing plasmid
clone
In order to demonstrate the practical advantage of work-
ing with a strain of higher genome stability, a plasmid-
based mutation screen was designed. Plasmid pSin32 car-
ries an inducible copy of sinI, coding for the SinI methyl-
transferase of Salmonella enterica serovar Infantis. SinI
methylates the inner cytosines in DNA at GG(A/T)CC
sites, producing 5-methylcytosine, thereby creating targets
for the McrBC endonuclease, which cleaves DNA contain-
ing methylcytosine. A plasmid that carries methylated SinI
sites (e.g., pSin32, self-methylated at its 8 SinI sites), there-
fore cannot establish itself in a mcrBC+ h o s t .T oc h e c k
what ratio of an induced pSin32 sample carries mutated
sinI (not expressing a functional SinI), the plasmid sample
0.0E+00
1.0E-07
2.0E-07
3.0E-07
4.0E-07
5.0E-07
6.0E-07
7.0E-07
8.0E-07
9.0E-07
1.0E-06
BL21(DE3)
MG 1655
MDS42
MDS42pdu
M
u
t
a
t
i
o
n
 
r
a
t
e
(
m
u
t
a
t
i
o
n
/
g
e
n
e
/
g
e
n
e
r
a
t
i
o
n
) IS elements
Point mutations
Deletions
Figure 5 Comparison of the mutational spectra of various strains. The bar graph shows the distribution of cycA mutation types, detected
by PCR analysis. The share of deletions (too low to be visible) is 1.6, 2.4, and 4.3% of the total mutations in MG1655, MDS42, and MDS42pdu,
respectively. No deletions were detected in BL21(DE3).
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(McrBC+), and colony numbers are compared (see
methods).
BL21(DE3)mcrBC, MDS42-T7, and MDS42pdu-T7
were transformed with pSin32. (While MDS42-T7 and
MDS42pdu-T7 are McrBC-, BL21(DE3) had to be speci-
fically deleted for mcrBC to be able to host the plasmid.)
Incidentally, it was found that, upon induction by IPTG,
production of the SinI enzyme had a moderate growth-
inhibiting effect even in McrBC- strains (Figure 6A).
While this moderate toxicity leads to an elevation in the
mutation rate of MDS42-T7, the effect is weaker (at a
marginal significance) in MDS42pdu-T7 (Figure 6B), sup-
porting the findings of the previous experiments.
Following IPTG-induction, plasmid samples were taken
at various intervals. The fraction of the plasmid sample
that carried sinI-disabling mutations (unmethylated plas-
mids) was detected by transforming the plasmid samples
back into MG1655 (mcrBC+). The total plasmid number
per sample was determined by simultaneously transform-
ing the samples into MDS42. After correcting each value
with the transformant number from a control plasmid for
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Figure 6 Toxic effect of the production of SinI. (A) Growth curves of MDS42-T7 (an McrBC- host) carrying pSin32 with and without IPTG
induction. Data are averages of the O.D.540 values of 25 independent colonies each, measured every 5 minutes using the Bioscreen C
automated instrument. (B) Mutation rates of uninduced and induced (SinI-expressing) cells. Mutation rates were measured using the cycA
fluctuation assay. Error bars represent 95% confidence intervals for the average of 3 independent measurements. ANOVA revealed a significance
of p < 0.01. Pairwise t-tests were conducted for the uninduced and induced pairs resulting in a significance of p = 0.077 and p = 0.067,
respectively.
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coding for functional/non-functional SinI was calculated
(Figure 7).
Surprisingly, 96.7% of the starting (0-hour) plasmid sam-
ple, originating from MDS42, could not be established in
MG1655. This indicated that, even in a host lacking T7
polymerase, spurious transcription of sinI had resulted in
SinI expression, and consequently, methylation of SinI
sites. The methylated status of the SinI sites in the original
plasmid sample was confirmed by their uncleavability by
SinI (data not shown).
Differences regarding clone stability in the different
strains became evident after IPTG-induction of SinI
expression. Thirty-six hours after transformation (28
hours after IPTG-induction), 51.7% of pSin32 harbored in
BL21(DE3)mcrBC cells carried mutations preventing the
production of active SinI. This value was significantly
lower in MDS42-T7 (25.8%, p < 0.005 with a two-tailed,
unpaired t-test). In MDS42pdu-T7, the fraction of
mutated pSin32 plasmids was even lower (8.2%, p <
0.005). The non-methylated status of the SinI sites on the
plasmids carrying a mutated sinI gene was confirmed by
their cleavability by SinI (data not shown).
It seemed evident, that accumulation of mutant plas-
mids in BL21(DE3)mcrBC and MDS42-T7 was due to a
combined effect of stress-induced mutagenesis and
growth inhibition by the SinI-expressing plasmid. Pro-
duction of the enzyme elevated mutation rates and
reduced growth. In these slow-growing cultures, over
time, SinI-inactivating mutations arose, which then, hav-
ing resumed their normal growth rate, quickly overgrew
the rest of the culture. In the low-mutation-rate
MDS42pdu-T7, SinI-inactivating mutations developed,
on average, over a longer time period. Growth curve
measurements of 50 independent colonies of MDS42-T7
and MDS42pdu-T7, all carrying the pSin32 plasmid, sup-
port this notion. An O.D.540 v a l u eo f0 . 7w a su s e da sa
cutoff to indicate that a culture had overcome the
growth-hindering effect of the induced plasmid. The
average time taken for MDS42pdu-T7 to reach this level
of density was significantly longer than for MDS42-T7
(727.8 and 571.8 minutes, respectively; P <0 . 0 0 5 ,t w o -
tailed, unpaired t test).
To verify that mutations had indeed taken place in the
plasmids that allowed for growth in McrBC+ cells, the sinI
region of 8 different plasmid samples (taken from viable,
pSin32-transformed MG1655 colonies) were sequenced
(Additional file 4). In seven out of the eight cases, a frame-
shift mutation had occurred in sinI, resulting in a new stop
codon within the gene. The eighth case displayed an A to
C transversion, resulting in the N255T mutation of the
protein. Six out of the seven new stop codons caused by
the frameshifts were located within the first 125 bp of the
gene.
Discussion
One of the major challenges that synthetic biology must
face is the intrinsic variability and genetic instability of
0
100
200
300
400
500
600
700
800
0 1 02 03 04 0
hours post transformation
m
u
t
a
n
t
s
 
p
e
r
 
1
0
0
0
 
p
l
a
s
m
i
d
s
BL21(DE3)mcrBC
MDS42-T7
MDS42pdu-T7
IPTG induction
Figure 7 Accumulation of plasmids with mutated sinI in various hosts. SinI methyltransferase was expressed from pSin32. Plasmids were
isolated at various intervals and screened (by transformation in McrBC+ and McrBC- hosts) for mutations resulting in loss of function of the
enzyme. Error bars represent 95% confidence intervals for the average of 3 independent measurements of mutant plasmid ratios. ANOVA
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systems increase, the emergence and selection of new
features will become a significant impediment in achiev-
ing robust and stable performance. Improving the
genetic stability of the host organism, or synthetic biolo-
gical chassis is therefore a validated goal.
Previously, we have demonstrated that genome stabiliza-
tion by elimination of mobile genetic elements has advan-
tages in certain cloning applications [18,20]. To achieve
additional genetic stabilization of the host, we targeted and
eliminated error-prone DNA polymerases (Pol II, Pol IV,
Pol V), major sources of frameshift and point mutations.
Possible alternative approaches to lower the mutation rate
include the introduction of a so-called antimutator dnaE
allele or upstream inactivation of the SOS response by
introducing a recA or lexA mutation. Previous studies on
the effect of antimutators found a 5 to 30 fold reduction in
mutation rate [56]. It was later shown that the mode of
action of these DnaE antimutators was a more effective
ability to exclude error-prone DNA polymerases at sites of
DNA synthesis during DSB-repair associated stress-
induced mutagenesis [57], suggesting that the elimination
of these enzymes would reproduce the antimutator effect.
Testing the other alternative approaches, MDS42recA,
compared to MDS42pdu, showed a much less pronounced
reduction in spontaneous mutation rate. Furthermore,
owing to the central role of the RecA enzyme in cell phy-
siology [58], unwanted pleiotropic effects might arise
within the cell, manifested, among others, in sensitivity to
mitomycin-C, presumably due to insufficient repair activity.
MDS42lexA(S119A), carrying a non-cleavable form of the
LexA repressor, did not significantly lower the mutation
rate under the conditions applied. The small effect of the
recA and lexA mutations can be explained by the relative
SOS-independence of the error-prone polymerases: the
enzymes are present even in unstressed cells, and can be
up-regulated by a number of (not just SOS) stress
responses (Figure 1) [45].
Several studies have been made on the effects of error-
prone polymerases on mutation rates using various strains
of E. coli and various methods of measurement. Support-
ing our findings is the observation that deletion of dinB
significantly decreases the mutation rates for both frame-
shift and base substitution mutations in a Lac
+ reversion
system, as well as in a rifampicin resistance assay [59]. In
another study, the lack of Pol V caused a decrease in the
number of Arg
+ growth dependent revertants [60]. Later
studies also showed that post-exposure mutation rates in
t h ep r e s e n c eo fc i p r o f l o x a c i nw e r em a r k e d l yr e d u c e d
when all three inducible polymerases were separately
eliminated [44].
Here, using a D-cycloserine resistance-based fluctua-
tion analysis [48], confirmed in some cases by a rifampi-
cin resistance assay as well, we carefully quantified the
effect of individual and combined error-prone polymer-
ase deletions on the mutation rate, under either
unstressed or stressed conditions. We determined that,
under unstressed conditions, elimination of each error-
prone polymerase by itself significantly decreased the
spontaneous mutation rate. The effect of combining dele-
tions ΔpolB and ΔdinB was additive, indicating an inde-
pendent mode of action for these polymerases. However,
ΔumuDC generated no additional decrease of the muta-
tion rate when any of the other two error prone poly-
merases was missing, possibly marking an interaction
among the genes or their products. This phenomenon
has been described previously regarding ΔdinB and
ΔumuDC, the nature of their putative interaction, how-
ever is not yet known [61].
As expected, the most dramatic differences in mutation
rate between MDS42 and MDS42pdu were observed
under various stress conditions. A sub-inhibitory concen-
tration of the SOS response-activating mitomycin-C, over-
production of either the non-toxic GFP protein or of the
highly toxic ORF238 hydrophobic protein all significantly
increased the mutation rate of MDS42. The values for
MDS42pdu remained stable under the same conditions. It
is also noteworthy, that among the strains tested, the com-
monly used production strain BL21(DE3) showed not just
the highest spontaneous mutation rate, but also the high-
est increase in mutation rates in response to the various
stresses. A difference of almost two orders of magnitude
was observed between the mutation rate of BL21(DE3)
and MDS42pdu when overproducing the toxic ORF238
protein. This elevated rate of mutation in BL21(DE3) can
be mostly attributed to an increased rate of IS insertions.
A clear practical advantage of working with MDS42pdu
was demonstrated in a protein production experiment,
where the SinI methyltransferase was expressed from an
inducible plasmid construct. SinI, producing 5-methylcy-
tosines is toxic to cells that carry the McrBC endonu-
clease. Even in cells lacking McrBC, we observed a
negative effect on cell fitness. When SinI was produced,
w ef o u n dt h a tt h esinI gene, carried on a plasmid, acquired
loss-of-function mutations approximately three times less
frequently in MDS42pdu than in MDS42, and over five
times less frequently than in BL21(DE3)mcrBC. Remark-
ably, after only 16 hours of production in BL21(DE3)
mcrBC, almost half of all sinI genes encoded on the plas-
mids had suffered a disabling mutation.
Clearly, the unexpectedly high ratio of mutated clones in
the SinI-expressing culture cannot be explained solely by
the stress-induced mutagenesis, the overall mutation rate
of which being too low in absolute values (in the order of
10
-6 mutations/gene/generation) to cause such a dramatic
effect. Rather, the phenomenon is in large part due to the
growth inhibitory effect of the plasmid carrying the toxic
gene. The chain of events is the following: Upon induction
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reduced. At the same time, mutation rate is increased by
the stress. Once a mutant, not producing the toxic protein,
arises in the plasmid population, the cell harboring it can
resume normal growth and become dominant in the cul-
ture. In low-mutation-rate MDS42pdu, appearance of
such mutants is delayed, and the cells can produce the
functional toxic protein for an extended period of time.
Calculating the precise advantage of MDS42pdu over
the parental MDS42 or the commonly used production
strain BL21(DE3) can be challenging, due to the stochastic
nature of mutagenesis, as well as the lack of exact data on
the fitness cost of overproduction. Nevertheless, it is clear
that the more severe the stress of overproducing a product
is (resulting in an elevated mutation rate and growth inhi-
bition), the greater the advantage of the stabilized host.
Conclusions
The mutation and inactivation of engineered genetic con-
structs within a host cell is an overlooked problem that
may have serious detrimental effects on the success of any
synthetic biological, molecular biological or biotechnologi-
cal process. A gene product imposing a metabolic burden
or being toxic to the host drives an evolutionary force that
selects for any mutants that alleviate the growth-inhibiting
effect. A host cell or chassis with enhanced genetic stabi-
l i t yi sa d v a n t a g e o u si nt h es t able maintenance of these
constructs. By eliminating the error-prone DNA polymer-
ase enzymes from the reduced-genome MDS42 strain
lacking all genomic IS elements, we have further stabilized
a strain that already showed clear advantages in cloning
applications. The resulting MDS42pdu strain had a signifi-
cant stabilizing effect on a toxic protein expression clone.
This high-fidelity strain, producing decreased genetic var-
iation in the culture, might also prove useful in applica-
tions ranging from the production of DNA therapeutics to
long-term continuous fermentation processes.
Methods
Strains, plasmids, media, and oligonucleotide primers
Most of the strains used in this study were constructed
from E. coli MDS42 [18], a reduced genome strain derived
from K-12 MG1655 [62]. Individual, scarless deletions
(polB, dinB, umuDC, mcrBC) or allele replacements (lexA)
were constructed by a suicide plasmid-based method.
Standard steps and plasmids (pST76-A, pSTKST) of the
procedure have been described [47]. Deletion of recA was
carried out with a similar strategy, using plasmid pSG2857
(Scarab Genomics, Madison, Wisconsin, USA). Individual
deletions were combined by P1 phage transduction [63] of
the marked (with integrated suicide-plasmids) intermedi-
ates of the deletion constructs, followed by endonuclease
cleavage-stimulated out-recombination and loss of the
plasmid. Co-ordinates of the individual deletions are
shown in Table 1. All deletions and modifications were
verified by PCR and sequencing using flanking primers.
T7 polymerase-expressing strain variants (MDS42-T7 and
MDS42pdu-T7) were constructed by replacing the yahA-
yaiL genomic region with an IPTG-inducible lac operator/
T7 polymerase cassette. Plasmid pSG-ORF238 is an IPTG-
inducible, pSG1144-based construct capable of overprodu-
cing the hydrophobic ORF238 toxic protein [20]. Plasmid
pET-GFP is an IPTG-inducible pET-based construct car-
rying the gfp gene. Plasmid pSin32 is a pET3-His based
construct [64] carrying an inducible, N-terminal His-
tagged sinI methyltransferase gene cloned into the XhoI
site of the original vector [65]. Plasmids were prepared
using IS-free MDS42 host. LB and LB-agar plates were
used for routine cultivation [66]. The following final anti-
biotic concentrations were used: 50 μg/ml ampicillin (Ap),
25 μg/ml chloramphenicol (Cm), 25 μg/ml kanamycin
(Kan), 100 μg/ml rifampicin (Rp), and 4 μg/ml D-cycloser-
ine (Cyc). For the cycA fluctuation assays, minimal salt
(MS) medium, supplemented with 0.2% glucose, was used
[26]. Growth measurements were made in MOPS minimal
defined medium (Scarab Genomics, Madison, Wisconsin,
USA). Additional file 5 lists the oligonucleotides used in
the experiments.
Growth measurements
Growth properties were evaluated in liquid medium in
100-well Honeycomb 2 plates (Oy Growth Curves Ab,
Helsinki, Finland). Growth curves were measured by fol-
lowing the optical densities (O.D.) at 540 nm in each well
using the Bioscreen C Automated Microbiology Growth
Analysis System (Oy Growth Curves Ab, Helsinki, Fin-
land). Fourteen individual colonies from each strain type
were resuspended and grown in parallel to saturation at
37°C in MOPS medium. From the saturated cultures, 2 μl
was transferred to 198 μl fresh MOPS medium and grown
to saturation in individual wells at 37°C using continuous
shaking. The median O.D. value of the fourteen parallel
cultures corresponding to each strain was calculated and
plotted for each time point. Doubling times were calcu-
lated from these growth curves using previously described
methods [67]. For analysis of growth in the presence of
the SinI methyltransferase, 50 resuspended individual
Table 1 Genomic coordinates of each scarless deletion
Strain Coordinates of deletion
MDS42recA 2820783-2821861
MDS42polB 63505-65764
MDS42dinB 250904-251966
MDS42umuDC 1230261-1231298
BL21(DE3)mcrBC 4408095-4515388
The data regarding the MDS42-based strains are given using MG1655
coordinates.
Csörgő et al. Microbial Cell Factories 2012, 11:11
http://www.microbialcellfactories.com/content/11/1/11
Page 10 of 13colonies of MDS42-T7 and MDS42pdu-T7, each harbor-
ing the pSin32 plasmid, were grown to saturation in LB
medium supplemented with 50 μg/ml ampicillin. From
the saturated cultures, 2 μl was transferred to 198 μlo f
fresh LB and ampicillin and grown to O.D. = 0.2, then
IPTG inducer was added at a final concentration of 1 mM.
An O.D.540 value of 0.7 was arbitrarily chosen as a point
where the culture had overcome the toxic effect of SinI.
The duration of the growth inhibition for each sample was
averaged for both strains.
To measure long-term survival of individual strains, 5 ml
LB cultures were inoculated 1:1000 (vol:vol) from fresh
overnight cultures. Viable counts were determined directly
from the cultures incubated at 37°C for up to one week.
Mutation rate measurements
D-cycloserine resistance assays were performed as pre-
viously described [48]. Briefly, in a fluctuation assay, 20
tubes of 1 ml MS medium [26] supplemented with 0.2%
glucose were inoculated with approximately 10
4 cells each,
and cultures were grown to early stationary phase. Ali-
quots of 50 μl from each tube were then spread on MS
plates containing D-cycloserine (0.04 mM). The number
of mutations per tube (m) was estimated from the number
of colonies by fluctuation analysis using the Ma-Sandri-
Sarkar maximum-likelihood method [68]. Equation
41 from the report of Stewart et al. [69] was used to extra-
polate the obtained m value, valid for 50 μl, to 1 ml. Statis-
tical comparisons of m values were made only when the
difference in total cell number was negligible (< 3%, P ≤
0.6, with a two-tailed, unpaired t test). The total number
of cells in a tube was calculated by spreading dilutions
from three random tubes onto nonselective plates. Divid-
ing the number of mutations per tube by the average total
number of cells in a tube gave the mutational rate (muta-
tion/gene/generation). To assess the effect of the antibiotic
mitomycin-C on mutation rate, 0.1 μg/ml of mitomycin-C
was added to each tube. When measuring mutation rates
of cells harboring a protein-overproducing plasmid, cul-
tures were induced with 1 mM IPTG at an O.D.540 value
of 0.2. In these cases the selective antibiotic for the specific
plasmid was also present in the MS medium.
In a second protocol, to confirm data obtained using the
cycA assay, cells resistant to rifampicin (carrying mutations
in rpoB [54]) were selected and counted. Twenty tubes of
1 ml LB were inoculated with 10
4 cells each, and cultures
were grown to early stationary phase. Appropriate dilu-
tions were spread onto non-selective LB agar plates and
LB agar plates containing rifampicin (100 μg/ml). Colony
counts were performed after 24 or 48 h, respectively.
Mutation frequencies were reported as a proportion of the
number of rifampicin-resistant colonies relative to the
total viable count. The results correspond to the mean
value obtained in three independent experiments for each
strain and condition. When required, different stress con-
ditions were provided in the same manner as in the cycA
assay.
Analysis of mutational spectra
Analysis of the mutational spectrum of the cycA gene has
been described previously [48]. In brief, a 1877-bp genomic
segment encompassing the entire gene was amplified from
mutant cells using the primer pair cycA-D/cycA-E. A
representative sample was obtained by analyzing 5 colonies
from each parallel plate, yielding a total of 96 samples per
experiment. The amplified fragments were resolved on an
agarose gel and compared to a fragment generated from
the wild-type template. Identical sizes indicated a mutation
affecting only one or a few nucleotides, a decrease in size
or failure of amplification indicated a deletion, and a
detectable increase in size indicated an IS insertion.
Assay to detect mutations in sinI
Plasmid pSin32 carries the gene sinI coding for SinI
methyltransferase of Salmonella enterica serovar Infantis
cloned into the XhoI site of the pET3-His plasmid [64].
The plasmid was electroporated into MDS42-T7,
MDS42pdu-T7 and BL21(DE3)mcrBC.A f t e r1h o u ro f
recovery incubation at 37°C in 1 ml LB, 100 μlo ft h e
transformed cultures were placed in 100 ml LB supple-
mented with Ap and incubated at 37°C. From the remain-
ing 900 μl, plasmid DNA was isolated according to
standard protocols [66]. After 7 hours of incubation, the
cultures reached O.D.540 = ~0.2, at which point the sam-
ples were induced with IPTG (1 mM final concentration).
Samples for plasmid preparation were also taken at this
time (8-hour samples), followed by additional samples
being taken every 2 hours, up to 18 hours, then at 24 and
36 hours of post-transformation growth. Purified pSin32
plasmid samples (9 from each strain) were then trans-
formed into MDS42 (McrBC
-) and MG1655 (McrBC
+). By
counting transformed MG1655 and MDS42 colonies for
each plasmid sample, the relative number of mutated plas-
mids could be calculated. To obtain an absolute value for
mutated plasmid numbers, each batch of electrocompetent
MDS42 and MG1655 indicator strains was transformed
with a control (pST76-A) plasmid [70] carrying an Ap
resistance cassette. The ratio of MG1655 and MDS42
transformants was then used as a correcting factor to cal-
culate absolute values for the number of mutated pSin32
plasmids for each sample.
Additional material
Additional file 1: shows the long-term survival rates of MDS42 and
MDS42pdu in stationary phase.
Additional file 2: shows the doubling times of T7 RNA polymerase
containing strains used in the study.
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Page 11 of 13Additional file 3: shows the mutation rates of MDS42 and
MDS42pdu under different conditions measured using a rifampicin
resistance assay.
Additional file 4: lists the mutations that occurred in eight
sequenced pSin32 plasmids isolated from McrBC+ hosts.
Additional file 5: lists the sequences and a short description of the
PCR primers used in the study.
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